Research Areas

Two reports landed the same week: one documenting rising pandemic risk, the other showing how little of the antiviral pipeline is ready to meet it. Then Ebola was declared a public health emergency.

The toughest problem to solve in drug development may not be finding new medicines, but building the infrastructure to make them reliably.

Discover how patient-derived organoids can be applied throughout the oncology drug development pipeline, demonstrated in colorectal cancer research.

Discover how patient-derived organoids can be applied throughout the oncology drug development pipeline, demonstrated in colorectal cancer research.

A first-in-human trial shows how computationally designed antigens could help shift vaccines from reactive to future-proof.

The MHRA-led sandbox will generate real-world evidence on AI tools that could improve medicines safety, reduce late-stage failures, and accelerate drug development.

​Microbubble-based genetic medicines, pharma deals, trial misses, and more led the news this week.

As drug discovery adopts more human-relevant models and complex biologics, it’s increasingly important that reagents are more consistent, better characterized, and fit for purpose.

Explore how 3D bioprinting is helping researchers create more realistic cancer models for studying tumor behavior, therapy response, and treatment resistance.

Learn how stability profiling and biophysical characterization support biologics candidate selection, formulation, and preclinical development.